Sep 16, 2014 - DCVax-L is the first product to receive formal designation as a “Promising Innovative Medicine” (PIM) under the new “Early Access to Medicines Scheme” (EAMS) launched in the UK in April 2014
March 2024. Six month to finishing a decade - “Early access to Medicines Scheme” - says it all and the relevance of this scheme